# Vir Biotechnology
 (stock symbol: VIR) Logo in transparent PNG and SVG formats

## Vir Biotechnology
 Logo icon format

### Vir Biotechnology
 Logo icon format Download PNG (47.71 KB)

![Vir Biotechnology
 Logo icon format Download PNG (47.71 KB)](/img/orig/VIR-55762507.png)

### Vir Biotechnology
 Logo icon format Download SVG (1.1 KB)

![Vir Biotechnology
 Logo icon format Download SVG (1.1 KB)](/img/orig/VIR-c24ba2db.svg)

## Vir Biotechnology
 Logo icon format for dark backgrounds

### Vir Biotechnology
 Logo icon format for dark backgrounds Download PNG (45.84 KB)

![Vir Biotechnology
 Logo icon format for dark backgrounds Download PNG (45.84 KB)](/img/orig/VIR.D-c45572ea.png)

### Vir Biotechnology
 Logo icon format for dark backgrounds Download SVG (1.1 KB)

![Vir Biotechnology
 Logo icon format for dark backgrounds Download SVG (1.1 KB)](/img/orig/VIR.D-14c2efe4.svg)

## About Vir Biotechnology


Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 for the prevention of influenza A virus; and VIR-1111 for the prevention of human immunodeficiency virus. The company has grant agreements with Bill & Melinda Gates Foundation and National Institutes of Health; an option and license agreement with Brii Biosciences Limited and Brii Biosciences Offshore Limited; a collaboration and license agreement with Alnylam Pharmaceuticals, Inc.; license agreements with The Rockefeller University and MedImmune, Inc.; collaboration with WuXi Biologics and Glaxo Wellcome UK Ltd.; and a collaborative research agreement with GlaxoSmithKline Biologicals SA. It also has a manufacturing agreement with Samsung Biologics Co.,Ltd. for the manufacture of SARS-COV-2 antibodies; and clinical collaboration with Gilead Sciences, Inc. for chronic hepatitis B virus. Vir Biotechnology, Inc. was incorporated in 2016 and is headquartered in San Francisco, California.

1. Website domain: vir.bio
2. Employees: 444
3. Marketcap: $3.36 Billion USD


## Categories
- [x] ðŸ‡ºðŸ‡¸ United States
- [x] ðŸ§¬ Biotech
